vimarsana.com
Home
Live Updates
Instylla First-In-Human Clinical Trial Published Results Dem
Instylla First-In-Human Clinical Trial Published Results Dem
Instylla First-In-Human Clinical Trial Published Results Demonstrate Technical Success and Persistent Embolization Across All Patients
/PRNewswire/ -- Instylla, Inc., a privately held company developing next-generation liquid embolics for peripheral vascular embolotherapy, today announced the...
Related Keywords
Taiwan ,
Gerards Goh ,
Helen Kavnoudias ,
Jee Fu Huang ,
Andrew Holden ,
Markd Goodwin ,
Department Of Internal Medicine ,
Kaohsiung Medical University Hospital ,
Instylla Inc ,
Internal Medicine ,
East Asia ,
Embrace Hydrogel Embolic System ,
Phasei First ,
Human Study ,
Polyethylene Glycol Based Liquid Embolic ,
Benign Hypervascular Tumors ,
Interventional Radiology ,
Water Based Liquid Embolic ,
Rabbit Kidney Model ,
Instylla Sprig Consulting ,